Your shopping cart is currently empty

FeTPPS, a decomposition catalyst for 5,10,15,20-tetrakis(4-sulfonatophenyl) porphyrin iron(III) chloride peroxynitrite, exhibits marked neuroprotective effects in experimental spinal cord injury models. It reduces cerebral tissue inflammation and damage, inhibits nitric oxide production and apoptosis, and may be employed in traumatic brain injury (TBI) research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $30 | - | In Stock | |
| 10 mg | $48 | - | In Stock | |
| 25 mg | $89 | - | In Stock | |
| 50 mg | $147 | - | In Stock | |
| 100 mg | $218 | - | In Stock | |
| 200 mg | $323 | - | In Stock |
| Description | FeTPPS, a decomposition catalyst for 5,10,15,20-tetrakis(4-sulfonatophenyl) porphyrin iron(III) chloride peroxynitrite, exhibits marked neuroprotective effects in experimental spinal cord injury models. It reduces cerebral tissue inflammation and damage, inhibits nitric oxide production and apoptosis, and may be employed in traumatic brain injury (TBI) research. |
| In vitro | Methods: HepG2 human hepatocellular carcinoma cells were treated with FeTPPS (5, 10, 15, 20, 25 μM for 12 hours), and cell viability was assessed via MTT assay. Results: FeTPPS protected cells from H₂O₂-induced oxidative damage.[2] |
| Molecular Weight | 1024.27 |
| Formula | C44H28ClFeN4O12S4 |
| Cas No. | 90384-82-0 |
| Smiles | O=S([O-])(C1=CC=C(C(C(C=C2)=[N]3C2=C(C4=CC=C5C(C6=CC=C(S(=O)([O-])=O)C=C6)=C7C=C8)C9=CC=C(S(=O)([O-])=O)C=C9)=C%10C=CC%11=C(C%12=CC=C(S(=O)([O-])=O)C=C%12)C8=[N]7[Fe+3]3([Cl-])([N-]45)[N-]%10%11)C=C1)=O.[H+].[H+].[H+].[H+] |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | H2O: 4 mg/mL (3.91 mM), Sonication and heating are recommended. | ||||||||||
Solution Preparation Table | |||||||||||
H2O
| |||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.